JNJ vs PFE
By Alex · Tickerpine
Johnson & Johnson vs Pfizer Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | PFE |
|---|---|---|
| Price | $273.14 | $28.57 |
| Market cap | $658.24B | $162.84B |
| P/E ratio | 31.7 | 37.6 |
| ROE | 25.74% | 5.01% |
| Profit margin | 21.48% | 6.80% |
| Revenue growth | 6.60% | 2.60% |
| Dividend yield | 1.96% | 6.15% |
| Beta | 0.23 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs PFE in plain English
- JNJ is the bigger company — about 4.0× the market cap of PFE.
- JNJ is cheaper on earnings (P/E 31.7 vs 37.6).
- JNJ earns a higher return on equity (26% vs 5%).
- JNJ is growing revenue faster (7% vs 3%).
- PFE has the higher dividend yield (6.15% vs 1.96%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
PFE return calculator
See what $1,000 in Pfizer Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.